The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia

Table 2

Characteristics of 563 febrile neutropenia episodes.

Patient characteristics	Total(n = 563)
Median (range) duration of fever prior to admission (days)	1 (0, 60)
Interval since the last chemotherapy (days) (median, range)	10 (0, 148)
Therapy preceding infection, n (%)
Induction	155 (27.5%)
Maintenance	68 (12.1%)
Disease status, n (%)
Remission	58 (21.7%)
Not remission	43 (16.1%)
Duration of neutropenia (days) (median, range)	8 (1, 49)
Duration of fever in days (median, range)	3 (1, 38)
White blood cell count on admission (cells/mm³) (median, range)	670 (10, 2, 35, 150)
Absolute neutrophil count on admission (cells/mm³) (median, range)	70 (0, 9, 522)
Antifungal therapy in the past 6 months	123 (21.8%)
G-CSF use before a specific cycle	164 (29.1%)
Steroid in the past 14 days	226 (40.1%)
Central venous catheter	226 (40.1%)
Central line	111 (19.8%)
PICC line	102 (18.1%)
Chemoport	10 (1.8%)
Hickmann	3 (0.5%)